Tango Therapeutics, Inc. (TNGX)
9.355
+0.26
(+2.80%)
USD |
NASDAQ |
Dec 12, 16:00
9.355
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Research and Development Expense (TTM): 132.82M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| XOMA Royalty Corp. | 2.295M |
| Viking Therapeutics, Inc. | 222.48M |
| Avanos Medical, Inc. | 22.70M |
| Krystal Biotech, Inc. | 55.37M |
| Moderna, Inc. | 3.271B |